The transmembrane β-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current I to

By Radicke Susanne  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 379, Iss. 6, 2009-06 ,pp. : 617-626

Springer Publishing Company

Access to resources Recommend Favorite

Novel Targets for Cardiac Antiarrhythmic Drug Development

By  

Current Pharmaceutical Design, Vol. 11, Iss. 15, 2005-06 ,pp. : 1959-1974

Bentham Science Publishers

Access to resources Recommend Favorite

Theoretical Possibilities for the Development of Novel Antiarrhythmic Drugs

By  

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite

Electropharmacology of Ro 22-9194, A New Antiarrhythmic Agent

By Kodama I.   Maruyama K.   Suzuki R.   Honjo H.   Toyama J.  

General Pharmacology, Vol. 27, Iss. 5, 1996-07 ,pp. : 755-760

Elsevier

Access to resources Recommend Favorite

New antiarrhythmic agents for atrial fibrillation and atrial flutter

By Pecini Redi   Elming Hanne   Pedersen Ole Dyg   Torp-Pedersen Christian  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 311-322

Informa Healthcare

Access to resources Recommend Favorite